Neuromodulation-Research Only
Device
Abbott Laboratories
Total Payments
$2.4M
Transactions
959
Doctors
102
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $122,122 | 50 | 0 |
| 2019 | $533,759 | 338 | 29 |
| 2018 | $1.2M | 427 | 77 |
| 2017 | $536,088 | 144 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.3M | 651 | 97.3% |
| Travel and Lodging | $27,368 | 63 | 1.2% |
| Consulting Fee | $18,425 | 25 | 0.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $11,145 | 1 | 0.5% |
| Food and Beverage | $7,639 | 219 | 0.3% |
Payments by Type
Research
$2.3M
651 transactions
General
$64,577
308 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| EValuating Anatomic vErsus TaRgeted Lead Placement for BurstDR TherapY During the Trial | Abbott Laboratories | $513,570 | 2 |
| MulTi-center pRospectIve stUdy deterMining the sustainability of Pain relief and psychosocial and functional responses wHen utilizing a multiple waveform enabled neurostimulator | Abbott Laboratories | $404,795 | 0 |
| TARGET A Post-Approval Study to Evaluate Targeted SCS (DRG) Stimulation for the management of Moderate to Severe Chronic Intractable Pain of the Lower Limbs due to CRPS types I and II | Abbott Laboratories | $404,128 | 3 |
| Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses When Utilizing a Multiple Waveform Enabled Neurostimulator | Abbott Laboratories | $228,873 | 0 |
| TRIUMPH | Abbott Laboratories | $193,972 | 1 |
| Long-Term Real-World Outcomes Study on Patients Implanted with a Neurostimulator | Abbott Laboratories | $168,867 | 1 |
| TARGET | Abbott Laboratories | $140,603 | 2 |
| PROGRESS | Abbott Laboratories | $53,354 | 0 |
| Target | Abbott Laboratories | $34,144 | 0 |
| Depression LTFU | Abbott Laboratories | $31,448 | 0 |
| Depression DBS CAP BRIO | Abbott Laboratories | $17,765 | 0 |
| DBS PD 5 yr | Abbott Laboratories | $15,490 | 0 |
| 15mm Surgical Mechanical Mitral Valve IDE Study | Abbott Laboratories | $14,885 | 0 |
| Depression DBS CAP | Abbott Laboratories | $13,735 | 0 |
| Motor Evoked Potentials in Current Steering and Ring Mode Stimulation | Abbott Laboratories | $13,000 | 0 |
| SUNBURST | Abbott Laboratories | $10,912 | 0 |
| Clinical Evaluation of the Infinity DBS System | Abbott Laboratories | $9,000 | 0 |
| Progress | Abbott Laboratories | $8,553 | 0 |
| ACCENT MRI PACEMAKER AND TENDRIL MRI LEAD IDE STUDY | Abbott Laboratories | $7,750 | 0 |
| DBS ET 5 yr | Abbott Laboratories | $6,585 | 0 |
Top Doctors Receiving Payments for Neuromodulation-Research Only
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Dallas, TX | $2.3M | 635 |
| Jason Pope | — | Santa Rosa, CA | $21,391 | 8 |
| , M.D., PH.D | Anesthesiology | San Diego, CA | $18,220 | 11 |
| , D.O | Physical Medicine & Rehabilitation | Napa, CA | $17,550 | 14 |
| , M.D | Interventional Pain Medicine | New York, NY | $7,983 | 8 |
| , MD | Pain Medicine | Chicago, IL | $6,800 | 12 |
| , MD | Physical Medicine & Rehabilitation | King Of Prussia, PA | $6,170 | 3 |
| , M.D., J.D | Neurology | Philadelphia, PA | $2,980 | 3 |
| , M.D | Pain Medicine | Scottsdale, AZ | $2,565 | 1 |
| , M.D | Neurological Surgery | Tyler, TX | $2,025 | 2 |
| , M.D | Family Medicine | Pittsfield, MA | $1,408 | 1 |
| , M.D | General Practice | Fort Lauderdale, FL | $1,125 | 3 |
| , M.D | Pain Medicine | Tualatin, OR | $663.82 | 6 |
| , MD, PHD | Specialist | Belleville, MI | $640.11 | 6 |
| , M.D | Interventional Pain Medicine | Maple Grove, MN | $639.07 | 6 |
| , M.D | Pain Medicine | Washington, DC | $629.02 | 6 |
| , D.O | Physical Medicine & Rehabilitation | Chandler, AZ | $612.53 | 5 |
| , M.D | Pain Medicine | Clifton, NJ | $589.07 | 5 |
| , MD | Anesthesiology | Post Falls, ID | $589.07 | 5 |
| , MD | Pain Medicine | Chattanooga, TN | $589.07 | 5 |
| , M.D., MPH | Internal Medicine | Canton, GA | $589.07 | 5 |
| , M.D | Pain Medicine | Staten Island, NY | $589.07 | 5 |
| , DO | Physical Medicine & Rehabilitation | Reno, NV | $512.71 | 8 |
| , MD | Interventional Pain Medicine | New York, NY | $507.82 | 6 |
| , M.D | Interventional Pain Medicine | Camarillo, CA | $428.93 | 6 |
Ad
Manufacturing Companies
- Abbott Laboratories $2.4M
Product Information
- Type Device
- Total Payments $2.4M
- Total Doctors 102
- Transactions 959
About Neuromodulation-Research Only
Neuromodulation-Research Only is a device associated with $2.4M in payments to 102 healthcare providers, recorded across 959 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2017 to 2020. In 2020, $122,122 was paid across 50 transactions to 0 doctors.
The most common payment nature for Neuromodulation-Research Only is "Unspecified" ($2.3M, 97.3% of total).
Neuromodulation-Research Only is associated with 20 research studies, including "EValuating Anatomic vErsus TaRgeted Lead Placement for BurstDR TherapY During the Trial" ($513,570).